Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Kinetic and stereochemical studies on novel inactivators of C-terminal amidation.
Feng J
,
Shi J
,
Sirimanne SR
,
Mounier-Lee CE
,
May SW
.
???displayArticle.abstract???
C-terminal amidation, a required post-translational modification for the bioactivation of many neuropeptides, entails sequential enzymic action by peptidylglycine alpha-mono-oxygenase (PAM, EC 1.14.17.3) and peptidylamidoglycolate lyase (PGL, EC 4.3.2.5). Here we introduce novel compounds in which an olefinic functionality is incorporated into peptide analogues as the most potent turnover-dependent inactivators of PAM. Kinetic parameters for PAM inactivation by 4-oxo-5-acetamido-6-phenyl-hex-2-enoic acid and 4-oxo-5-acetamido-6-(2-thienyl)-hex-2-enoic acid were obtained by using both the conventional dilution assay method and the more complex progress curve method. The results obtained from the progress curve method establish that these compounds exhibit the kinetic characteristics of pure competitive inactivators (i.e. no ESI complex forms during inactivation). On the basis of k(inact)/K(i) values, 4-oxo-5-acetamido-6-(2-thienyl)-hex-2-enoic acid is almost two orders of magnitude more potent than benzoylacrylate, a chemically analogous olefinic inactivator that lacks the peptide moiety. Stereochemical studies established that PAM inactivation by 4-oxo-5-acetamido-6-(2-thienyl)-hex-2-enoic acid is stereospecific with respect to the moiety at the P(2) position, which is consistent with previous results with substrates and reversible inhibitors. In contrast, 2, 4-dioxo-5-acetamido-6-phenylhexanoic acid, which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and dopamine-beta-hydroxylase.
Bradbury,
4-Phenyl-3-butenoic acid, an in vivo inhibitor of peptidylglycine hydroxylase (peptide amidating enzyme).
1990, Pubmed
Bradbury,
4-Phenyl-3-butenoic acid, an in vivo inhibitor of peptidylglycine hydroxylase (peptide amidating enzyme).
1990,
Pubmed
Bradbury,
Biosynthesis of the C-terminal amide in peptide hormones.
1987,
Pubmed
Chen,
Inactivation kinetics of the reduced spinach chloroplast fructose-1,6-bisphosphatase by subtilisin.
1997,
Pubmed
Eipper,
Peptide alpha-amidation.
1988,
Pubmed
Hartmann,
Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type.
1992,
Pubmed
Kato,
Two enzymes concerned in peptide hormone alpha-amidation are synthesized from a single mRNA.
1990,
Pubmed
Katopodis,
A novel enzyme from bovine neurointermediate pituitary catalyzes dealkylation of alpha-hydroxyglycine derivatives, thereby functioning sequentially with peptidylglycine alpha-amidating monooxygenase in peptide amidation.
1990,
Pubmed
Katopodis,
Functional and structural characterization of peptidylamidoglycolate lyase, the enzyme catalyzing the second step in peptide amidation.
1991,
Pubmed
Katopodis,
Novel substrates and inhibitors of peptidylglycine alpha-amidating monooxygenase.
1990,
Pubmed
Klinman,
Mechanisms Whereby Mononuclear Copper Proteins Functionalize Organic Substrates.
1996,
Pubmed
Li,
NN-dimethyl-1,4-phenylenediamine as an alternative reductant for peptidylglycine alpha-amidating mono-oxygenase catalysis.
1994,
Pubmed
May,
Dopamine-B-hydroxylase: suicide inhibition by the novel olefinic substrate, 1-phenyl-1-aminomethylethene.
1983,
Pubmed
Merkler,
The inactivation of bifunctional peptidylglycine alpha-amidating enzyme by benzylhydrazine: evidence that the two enzyme-bound copper atoms are nonequivalent.
1995,
Pubmed
Merkler,
The irreversible inactivation of two copper-dependent monooxygenases by sulfite: peptidylglycine alpha-amidating enzyme and dopamine beta-monooxygenase.
1995,
Pubmed
Moore,
Kinetic and inhibition studies on substrate channelling in the bifunctional enzyme catalysing C-terminal amidation.
1999,
Pubmed
,
Xenbase
Mounier,
Pyruvate-extended amino acid derivatives as highly potent inhibitors of carboxyl-terminal peptide amidation.
1997,
Pubmed
,
Xenbase
Murthy,
Further characterization of peptidylglycine alpha-amidating monooxygenase from bovine neurointermediate pituitary.
1987,
Pubmed
Ogonowski,
Antiinflammatory and analgesic activity of an inhibitor of neuropeptide amidation.
1997,
Pubmed
Ortiz de Montellano,
Destruction of cytochrome P-450 by vinyl fluoride, fluroxene, and acetylene. Evidence for a radical intermediate in olefin oxidation.
1982,
Pubmed
Padgette,
Olefin oxygenation and N-dealkylation by dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
1985,
Pubmed
Perkins,
The 108-kDA peptidylglycine alpha-amidating monooxygenase precursor contains two separable enzymatic activities involved in peptide amidation.
1990,
Pubmed
Ping,
Reaction versus subsite stereospecificity of peptidylglycine alpha-monooxygenase and peptidylamidoglycolate lyase, the two enzymes involved in peptide amidation.
1995,
Pubmed
Prigge,
Amidation of bioactive peptides: the structure of peptidylglycine alpha-hydroxylating monooxygenase.
1997,
Pubmed
Rizzo,
Co-oligopeptides of aromatic amino acids and glycine with a variable distance between the aromatic residues. VI. Circular dichroism studies of Co-oligopeptides of l-phenylalanine, L-tryptophan, and glycine.
1977,
Pubmed
Schechter,
On the size of the active site in proteases. I. Papain.
1967,
Pubmed
Silverman,
Mechanism-based enzyme inactivators.
1995,
Pubmed
Suzuki,
Elucidation of amidating reaction mechanism by frog amidating enzyme, peptidylglycine alpha-hydroxylating monooxygenase, expressed in insect cell culture.
1990,
Pubmed
,
Xenbase
Tajima,
The reaction product of peptidylglycine alpha-amidating enzyme is a hydroxyl derivative at alpha-carbon of the carboxyl-terminal glycine.
1990,
Pubmed
Takahashi,
Peptidylglycine alpha-amidating reaction: evidence for a two-step mechanism involving a stable intermediate at neutral pH.
1990,
Pubmed
Tamburini,
Peptide substrate specificity of the alpha-amidating enzyme isolated from rat medullary thyroid CA-77 cells.
1990,
Pubmed
Tamburini,
Structure-activity relationships for glycine-extended peptides and the alpha-amidating enzyme derived from medullary thyroid CA-77 cells.
1988,
Pubmed
Tian,
Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.
1982,
Pubmed
Tsou,
Kinetics of substrate reaction during irreversible modification of enzyme activity.
1988,
Pubmed
Vanden Bossche,
R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis.
1990,
Pubmed
Wang,
Kinetics of inactivation of aminoacylase by 2-chloromercuri-4-nitrophenol: a new type of complexing inhibitor.
1995,
Pubmed
Wang,
An alternative method for determining inhibition rate constants by following the substrate reaction.
1990,
Pubmed
Wang,
Kinetics of suicide substrates.
1990,
Pubmed
Wu,
Activation mechanism and modification kinetics of Chinese hamster dihydrofolate reductase by p-chloromercuribenzoate.
1998,
Pubmed
